Martinrea International (MRE) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 delivered strong results with higher margins, robust free cash flow, and operational improvements, outperforming peers operationally and financially.
Total sales were $1,275.5M, down 2.0% year-over-year, with production sales declining 5.1% and tooling sales up 100.3%.
Adjusted operating income margin improved to 6.8%, up 50 bps year-over-year and 150 bps sequentially.
Free cash flow before IFRS 16 lease payments was $72M, up from $51.7M YoY; including leases, $57.9M.
Machine learning initiatives, SG&A cost reductions, and restructuring drove performance and future margin potential.
Financial highlights
Adjusted operating income was $86.1M, up from $81.6M in Q2 2024, with a 6.8% margin (up 50 bps YoY).
Adjusted net earnings per share rose to $0.66 from $0.58 YoY, aided by lower interest expense and tax rate.
Net debt (ex-IFRS 16) fell by $73M to $792M; net debt/EBITDA at 1.5x, meeting target.
Adjusted EBITDA was $165.4M (13.0% margin), up from 12.8% YoY.
Gross margin for Q2 2025 was $184.5M (14.5% of sales), up 0.4 percentage points YoY.
Outlook and guidance
2025 outlook reaffirmed: sales of $4.8B–$5.1B, adjusted operating margin 5.3%–5.8%, free cash flow $125M–$175M.
Free cash flow expected at the high end of the range, supported by CapEx discipline and working capital optimization.
Expect lower production sales and margins in H2 due to seasonality and contractual price reductions.
Outlook excludes impacts of tariffs, government policy changes, and anticipates $55M in cash restructuring costs for 2025.
Margin expansion in 2026 possible from $50M SG&A savings, AI/process improvements, and new contract pricing.
Latest events from Martinrea International
- Record Free Cash Flow and margin gains in 2025 set the stage for continued growth and expansion.MRE
Q4 20255 Mar 2026 - Record Q2 adjusted EBITDA, strong cash flow, and stable 2024 outlook despite industry headwinds.MRE
Q2 20242 Feb 2026 - Q3 saw lower sales and earnings but stronger margins, cash flow, and improved leverage.MRE
Q3 202414 Jan 2026 - Impairments and lower sales drove a net loss, but Free Cash Flow and margins remained resilient.MRE
Q4 20243 Dec 2025 - Sales and margins declined year-over-year, but new awards and cost focus support future outlook.MRE
Q1 202528 Nov 2025 - Margins and adjusted EPS improved in Q3 2025 despite lower sales and free cash flow.MRE
Q3 202515 Nov 2025